Browse by author
Lookup NU author(s): Dr Sasha Gartside
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
We report the effects of the monoamine oxidase inhibitor, tranylcypromine, combined with the 5-HT1A receptor antagonist, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl cyclohexanecarboxamide (WAY 100635), on both 5-hydroxytryptamine (5-HT) cell firing and cortical extracellular 5-HT in the rat. Tranylcypromine inhibited 5-HT cell firing in the dorsal raphe nucleus dose-dependently (ED50 5 mg/kg i.v.). In microdialysis experiments, tranylcypromine (5 mg/kg i.v.) increased extracellular 5-HT in the frontal cortex. WAY 100635 (0.1 mg/kg i.v.) both reversed the inhibition of 5-HT cell firing and facilitated the increase in extracellular 5-HT. In conclusion, WAY 100635 enhances the effect of tranylcypromine on presynaptic 5-HT function. These data are relevant to clinical evidence that co-therapy with a 5-HT1A receptor antagonist improves the antidepressant efficacy of a monoamine oxidase inhibitor.
Author(s): Sharp T, Gartside SE, Umbers V
Publication type: Article
Publication status: Published
Journal: European Journal of Pharmacology
Print publication date: 05/02/1997
ISSN (print): 0014-2999
ISSN (electronic): 1879-0712
Notes: 0014-2999 (Print)
Altmetrics provided by Altmetric